Related Experiment Videos

Effects of C2-ceramide on the Malme-3M melanoma cell line

Won Suk Han1, Jong Yeop Yoo, Sang Woong Youn

  • 1Department of Dermatology, Seoul National University Hospital, 28, Youngon-Dong, Chongno-Gu, 110-744, Seoul, South Korea.

Insights

Cell-permeable ceramide (C2-ceramide) inhibits human melanoma cell growth by halting DNA synthesis and increasing G0/G1 phase, without inducing apoptosis. Increased HSP70 expression may contribute to this resistance.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Dermatology

Background:

  • Ceramides regulate cell proliferation, differentiation, and apoptosis.
  • Limited research exists on ceramide's effects on melanocyte growth and melanogenesis.

Purpose of the Study:

  • Investigate the impact of cell-permeable ceramide on human melanoma cell line Malme-3M.
  • Determine ceramide's effects on cell growth, cell cycle, apoptosis, melanogenesis, and key signaling pathways.

Main Methods:

  • MTT proliferation assay to assess cell viability.
  • Cell cycle analysis and flow cytometry for apoptosis detection.
  • Western blot to analyze ERK and Akt activation, and caspase-3 and HSP70 levels.

Main Results:

  • C2-ceramide inhibited Malme-3M cell growth in a dose-dependent manner.
  • Cell cycle analysis revealed reduced S phase and increased G0/G1 phase, indicating inhibited DNA synthesis.
  • Apoptosis was not induced; instead, HSP70 expression increased moderately, suggesting a role in apoptosis resistance.
  • Tyrosinase activity and melanin synthesis showed only slight decreases.
  • Akt phosphorylation decreased, while ERK activation was transient.

Conclusions:

  • C2-ceramide effectively inhibits Malme-3M melanoma cell growth without inducing apoptosis.
  • The observed increase in HSP70 may be linked to the cells' resistance to apoptosis.
  • Ceramide's signaling pathway involves modulation of Akt and ERK, impacting cell proliferation.

Related Concept Videos